Pages with the fewest revisions

From IDWiki

Showing below up to 50 results in range #151 to #200.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. CR:DOI:f4f4f2345f21b543768964b5b3a01098‏‎ (1 revision)
  2. Yeasts‏‎ (1 revision)
  3. CR:DOI:5245c9c2c02e57bbe2569cc7ae922875‏‎ (1 revision)
  4. Staphylococcus auricularis‏‎ (1 revision)
  5. Neonatal HCV‏‎ (1 revision)
  6. CR:DOI:5d7d49c217f237f08ec448838ccf2716‏‎ (1 revision)
  7. Propofol infusion syndrome‏‎ (1 revision)
  8. CR:DOI:6a258ac530bd06281c5a3ffc05a8e766‏‎ (1 revision)
  9. Drug-induced lupus‏‎ (1 revision)
  10. Bacillary angiomatosis‏‎ (1 revision)
  11. Cardiac anatomy‏‎ (1 revision)
  12. CR:DOI:76eef683079d96f46f56a6eccb733f17‏‎ (1 revision)
  13. HIV wasting syndrome‏‎ (1 revision)
  14. Certolizumab pegol‏‎ (1 revision)
  15. CR:DOI:80ac657299c1a711fa7215edaa1fadcc‏‎ (1 revision)
  16. Leukoerythroblastic reaction‏‎ (1 revision)
  17. ECOG‏‎ (1 revision)
  18. Bone marrow biopsy‏‎ (1 revision)
  19. CR:DOI:9001a5594f91dd6bf04eed25ac6ece98‏‎ (1 revision)
  20. Tick bite prevention‏‎ (1 revision)
  21. Regular narrow-complex tachycardia‏‎ (1 revision)
  22. Löfgren syndrome‏‎ (1 revision)
  23. Bradycardia‏‎ (1 revision)
  24. Achromobacter‏‎ (1 revision)
  25. CR:DOI:9d68353d98e4176c52cd7ca96bd0a5ee‏‎ (1 revision)
  26. Hepatocellular carcinoma‏‎ (1 revision)
  27. CR:DOI:a8362c6508ab63096f217e5911a3d0f9‏‎ (1 revision)
  28. Traumatic brain injury‏‎ (1 revision)
  29. Paraneoplastic cerebellar degeneration‏‎ (1 revision)
  30. Marginal zone lymphoma‏‎ (1 revision)
  31. High dose ARA-C‏‎ (1 revision)
  32. Acute loss of consciousness‏‎ (1 revision)
  33. CR:DOI:b7d2eb575c72075fbc611e031639265c‏‎ (1 revision)
  34. Membranous nephropathy‏‎ (1 revision)
  35. Hydralazine‏‎ (1 revision)
  36. CR:DOI:0b4b004dd3ae98c4f75ebf3cff47e3ab‏‎ (1 revision)
  37. CR:DOI:c5086c57c4ad4641b7ee0e15b2ed35a2‏‎ (1 revision)
  38. CR:DOI:176b5770c3f3682ece04fcb9d7722a0c‏‎ (1 revision)
  39. Alcohol, smoking and substance involvement screening test‏‎ (1 revision)
  40. CR:DOI:ceeb91106002ee6438eacfb26f0b10a7‏‎ (1 revision)
  41. Perioperative management of liver disease‏‎ (1 revision)
  42. Model for end-stage liver disease‏‎ (1 revision)
  43. Immune effector cell-associated neurotoxicity syndrome‏‎ (1 revision)
  44. CR:DOI:223da6637bb9228360819cb97fb77f2f‏‎ (1 revision)
  45. CR:DOI:d64cba150222bda1903d3709cedc7c2a‏‎ (1 revision)
  46. Vasopressors and inotropes‏‎ (1 revision)
  47. Pharyngitis‏‎ (1 revision)
  48. Moya moya syndrome‏‎ (1 revision)
  49. CR:DOI:2f556ae27a0ead10bdc78afc7d591782‏‎ (1 revision)
  50. CR:DOI:e685b2d71da14c2ca90bb1aeff3daa02‏‎ (1 revision)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)